Metropolis Healthcare's Q4 FY 2025-26 Quarterly Results

Result Summary

• Metropolis Healthcare Ltd reported a 4.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 22.9%.
• Its expenses for the quarter were up by 4.2% QoQ and 14.9% YoY.
• The net profit increased 21.1% QoQ and increased 74.3% YoY.
• The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 2.46 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Metropolis Healthcare Ltd is a prominent player in the healthcare and diagnostics industry. The company is primarily engaged in providing diagnostic testing services, which include a wide range of pathology tests and related healthcare services. As a leader in this sector, Metropolis Healthcare has established a significant market presence across various regions, offering comprehensive diagnostic solutions to cater to the growing demand for healthcare services. Recent major developments within the company are not available from the provided data. The company's focus on quality and accuracy in diagnostics positions it as a trusted name in the healthcare space.

Revenue

In the fourth quarter of fiscal year 2026, Metropolis Healthcare Ltd reported a total income of ₹432.84 crores, marking a 4.3% increase compared to the third quarter of the same year, which recorded a total income of ₹414.93 crores. On a year-over-year basis, there was a substantial increase of 22.9%, as the total income in the fourth quarter of fiscal year 2025 was ₹352.26 crores. This growth reflects the company's ability to enhance its revenue streams over both the quarterly and annual periods, indicating a consistent upward trajectory in income generation.

Profitability

For the fourth quarter of fiscal year 2026, Metropolis Healthcare Ltd achieved a profit before tax of ₹69.76 crores, which represents a quarter-over-quarter increase of 22.0% from ₹57.16 crores in the third quarter of the same fiscal year. Compared to the fourth quarter of fiscal year 2025, there was a significant year-over-year growth of 93.6% from ₹36.04 crores. After accounting for taxes, the profit after tax stood at ₹50.96 crores for Q4FY26, exhibiting a 21.1% rise from the previous quarter's ₹42.09 crores, and a 74.3% increase over the same quarter in the previous year, which recorded ₹29.23 crores. These figures highlight a notable improvement in profitability.

Operating Metrics

During the fourth quarter of fiscal year 2026, Metropolis Healthcare Ltd's total expenses amounted to ₹363.18 crores, which was a 4.2% increase from the third quarter's total expenses of ₹348.67 crores. On an annual comparison, there was a 14.9% rise from the fourth quarter of fiscal year 2025, which recorded expenses of ₹316.22 crores. The earnings per share (EPS) for Q4FY26 was ₹2.46, reflecting a sharp decline of 69.0% from the previous quarter's EPS of ₹7.94. Year-over-year, the EPS decreased by 56.5% from ₹5.66 in Q4FY25. This indicates fluctuations in earnings per share despite overall growth in income and profits.